In a report released today, Michael Petusky from Barrington maintained a Buy rating on Tivity Health Inc (TVTY), with a price target of $50. The company’s shares closed yesterday at $35.12.
Petusky observed:
“We expect an acceleration of revenue growth in Q4 driven largely by the company’s Prime business, which is expected to benefit from certain promotional activities.”
According to TipRanks.com, Petusky is a 5-star analyst with an average return of 12.9% and a 61.9% success rate. Petusky covers the Services sector, focusing on stocks such as US Physical Therapy, BioScrip Inc, and Henry Schein.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tivity Health Inc with a $47.25 average price target, which is a 34.5% upside from current levels. In a report released yesterday, Cantor Fitzgerald also maintained a Buy rating on the stock with a $49 price target.
.
See today’s analyst top recommended stocks >>
Tivity Health Inc’s market cap is currently $1.4B and has a P/E ratio of 20.81. The company has a Price to Book ratio of 4.39.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tivity Health, Inc. engages in the development and provision of network solutions and health management services. It offers rehabilitative therapy, chiropractic procedure, alternative medicines, and health and fitness programs under the SilverSneakers, Prime Fitness, and WholeHealth Living trademarks.
